Aralez Pharmaceuticals Inc. (TSE:ARZ – Get Free Report) was up 10.3% during trading on Monday . The stock traded as high as C$0.51 and last traded at C$0.43. Approximately 274,400 shares traded hands during trading, an increase of 247% from the average daily volume of 79,103 shares. The stock had previously closed at C$0.39.
Aralez Pharmaceuticals Stock Performance
The company’s 50-day moving average price is C$0.43.
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc operates as a specialty pharmaceutical company in the United States and Canada. It engages in acquiring, developing, and commercializing products in the areas of cardiovascular, pain management, dermatological allergy, and other indications. It offers Zontivity for the reduction of thrombotic cardiovascular events in patients with heart attack or peripheral arterial disease; Toprol-XL, a cardioselective beta-blocker that is indicated for the treatment of hypertension; Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia and patients with primary hypercholesterolemia or mixed dyslipidemia; and Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial.
Featured Articles
- Five stocks we like better than Aralez Pharmaceuticals
- What is a Special Dividend?
- United Airlines Soars on Earnings Beat
- Using the MarketBeat Dividend Tax Calculator
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
